Response to Wise et al. (Tiotropium safety in real life populations).
作者信息
Schmiedl Sven, Thürmann Petra, Fischer Rainald, Rottenkolber Dominik, Rottenkolber Marietta
机构信息
Department of Clinical Pharmacology, School of Medicine, Faculty of Health, Witten/Herdecke University, Witten.
Philipp Klee-Institute for Clinical Pharmacology, HELIOS Clinic Wuppertal, Wuppertal.
出版信息
Br J Clin Pharmacol. 2016 Aug;82(2):564-5. doi: 10.1111/bcp.12970. Epub 2016 May 20.
Abstract
摘要
相似文献
1
Response to Wise et al. (Tiotropium safety in real life populations).
Br J Clin Pharmacol. 2016 Aug;82(2):564-5. doi: 10.1111/bcp.12970. Epub 2016 May 20.
2
[The efficacy and safety of low-dose tiotropium bromide inhaled via Respimat® in patients with chronic obstructive pulmonary disease].
Zhonghua Nei Ke Za Zhi. 2014 Dec;53(12):964-8.
3
Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease.
N Engl J Med. 2017 Sep 7;377(10):923-935. doi: 10.1056/NEJMoa1700228.
4
[The efficacy and safety of tiotropium/olodaterol fixed-dose combination in Chinese patients with chronic obstructive pulmonary disease: a pooled subgroup analysis of TONADO 1+2].
Zhonghua Jie He He Hu Xi Za Zhi. 2019 Nov 12;42(11):838-844. doi: 10.3760/cma.j.issn.1001-0939.2019.11.010.
5
Bronchodilator efficacy of 18 μg once-daily tiotropium inhalation via Discair versus HandiHaler in adults with chronic obstructive pulmonary disease: randomized, active-controlled, parallel-group, open-label, Phase IV trial.
Int J Chron Obstruct Pulmon Dis. 2016 Nov 22;11:2859-2867. doi: 10.2147/COPD.S119114. eCollection 2016.
6
Bronchodilator Effect of Tiotropium via RespimatAdministered with a Spacer in Patients with Chronic Obstructive Pulmonary Disease (COPD).
Intern Med. 2017 Sep 15;56(18):2401-2406. doi: 10.2169/internalmedicine.8255-16. Epub 2017 Aug 21.
7
Clinical improvement by tiotropium plus olodaterol.
Respir Med. 2017 Apr;125:104. doi: 10.1016/j.rmed.2016.03.010. Epub 2016 Mar 18.
8
[Efficacy and safety of tiotropium Respimat in the treatment of chronic obstructive pulmonary disease: systematic review].
Zhonghua Jie He He Hu Xi Za Zhi. 2017 Aug 12;40(8):596-603. doi: 10.3760/cma.j.issn.1001-0939.2017.08.011.
9
10
Tiotropium Respimat(®) Versus HandiHaler(®): Comparison of Bronchodilator Efficacy of Various Doses in Clinical Trials.
Adv Ther. 2016 May;33(5):786-93. doi: 10.1007/s12325-016-0322-9. Epub 2016 Mar 28.
本文引用的文献
1
Tiotropium safety in 'real-world' populations: Response to Schmiedl, et al. in the British Journal of Clinical Pharmacology.
Br J Clin Pharmacol. 2016 Aug;82(2):562-3. doi: 10.1111/bcp.12972. Epub 2016 May 19.
2
Comparative Cardiovascular and Cerebrovascular Safety of Inhaled Long-Acting Bronchodilators in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study.
Pharmacotherapy. 2016 Jan;36(1):26-37. doi: 10.1002/phar.1684.
3
Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial.
NPJ Prim Care Respir Med. 2015 Nov 5;25:15067. doi: 10.1038/npjpcrm.2015.67.
4
Tiotropium Respimat(®) vs. HandiHaler(®): real-life usage and TIOSPIR trial generalizability.
Br J Clin Pharmacol. 2016 Feb;81(2):379-88. doi: 10.1111/bcp.12808. Epub 2015 Dec 23.
5
Cardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial.
Respir Res. 2015 Jun 2;16(1):65. doi: 10.1186/s12931-015-0216-4.
6
Inhaled bronchodilators and the risk of tachyarrhythmias.
Int J Cardiol. 2015;190:133-9. doi: 10.1016/j.ijcard.2015.04.129. Epub 2015 Apr 17.
7
Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease.
Int J Chron Obstruct Pulmon Dis. 2015 Mar 16;10:549-64. doi: 10.2147/COPD.S71913. eCollection 2015.
8
Risk of acute urinary retention associated with inhaled anticholinergics in patients with chronic obstructive lung disease: systematic review.
Ther Adv Drug Saf. 2013 Feb;4(1):19-26. doi: 10.1177/2042098612472928.
9
Tiotropium and the risk of death in COPD.
N Engl J Med. 2014 Jan 30;370(5):481-2. doi: 10.1056/NEJMc1314411.
10
Tiotropium and the risk of death in COPD.
N Engl J Med. 2014 Jan 30;370(5):480-1. doi: 10.1056/NEJMc1314411.
Zotero 插件